Latest Stories


Welcome To The New Dark Reading

Monday 31 March

UBM Tech Unveils the New Dark Reading Information Security Community Site

Creates Online Community for Cyber Security News, Commentary and Discussions

UBM Tech

1

3

1

Dr. Barbara Nusbaum, Psychologist and Money Coach

Monday 31 March

Americans Curiously Passive About Financial Education, Hurting Prospects for a Comfortable Retirement, Genworth Study Finds

Americans recognize that as they become more financially savvy they are more likely to have a larger nest egg at retirement.

Genworth Financial

2

2

1

Get refund from Vioxx Settlement

Monday 31 March

Get refund from Vioxx Settlement

A settlement was reached with the manufacturer of Vioxx and will provide refunds to anyone who paid for the medication.

Herman, Herman & Katz, LLC and Leiff Cabraser Heim

1

The New Platform Offers The Best Video Content Hand Curated Across Nearly 100 Channels Ranging From Music to Sports to Comedy and Of Course… Cats

Monday 31 March

Pluto.TV Launches Free Online Television Experience That's Out Of This World

The New Platform Offers The Best Video Content Hand Curated Across Nearly 100 Channels Ranging From Music to Sports to Comedy and Of Course… Cats

Pluto.TV

3

1

Role of RAS Biomarker Testing in mCRC - Learn more about the steps taken by doctors to select an appropriate treatment for a person newly diagnosed with metastatic colorectal cancer.

Monday 31 March

New Global Initiative Aims to Improve Patient Outcomes in Metastatic Colorectal Cancer

The multidisciplinary Oncology Partnership and Education Network (OPEN) aims to improve patient outcomes in oncology, with initial focus on metastatic colorectal cancer (mCRC)

Merck Serono

3

3

U.S. Burden of Cardiovascular Disease Infographic

Monday 31 March

Data From Phase 3 Pivotal Studies Show Amgen's Novel Investigational Cholesterol-Lowering Medication Evolocumab Significantly Reduced LDL Cholesterol In Statin Intolerant Patients And In Patients On Statins

Data From Two Separate Phase 3 Studies of Evolocumab (AMG 145), a PCSK9 Inhibitor, Presented in Late-Breaking Clinical Trials Session at ACC.14 - Data Add to the Three Pivotal Studies Presented Yesterday

Amgen

1

1

Saxo Bank’s Profits Grow as Clients’ Collateral Deposits Reach All-Time High

Friday 28 March

Saxo Bank's Profits Grow as Clients' Collateral Deposits Reach All-time High

Saxo Bank, the online trading and investment specialist, saw clients’ collateral deposits increase by 26% to DKK 50.6 billion by the end of the year, which is a new all-time high. This is a very positive development as clients’ funds held as collateral are the basis for future trading and investment by clients on the Bank’s platform and also serve as a very clear indication of the customer appeal of Saxo Bank’s global, multi-asset strategy.

Saxo Bank

1

Novo Nordisk launches ’Cities Changing Diabetes’ to fight urban diabetes

Friday 28 March

Novo Nordisk Launches 'Cities Changing Diabetes' to Fight Urban Diabetes

Novo Nordisk today announces the launch of ‘Cities Changing Diabetes’, an ambitious new partnership programme to fight the urban diabetes challenge.

Novo Nordisk A/S

1

5

4

Subscribe via RSS

RSSAll Content
RSSConsumer
RSSEntertainment
RSSFinancial
RSSGovernment
RSSHealthcare
RSSRetail
RSSTechnology

Register

Journalists who register may create email subscriptions to search results and a cart of assets to download. Click here to login, register or edit profile.

What Our Users
Are Saying

"I like the way the DC is easy to navigate, easy to find stories, easy to find when they were filed so you know if they’re out of date, and easy to see an on-line version of the available video" -- Allan C Lee, Director of News and Current Affairs